Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)
Study Identifier:
AA-HPP-208
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete
Study Details
Medical Condition
- Unmapped
Study Drug
- Drug: Asfotase alfa
Date
Jun 2016 - Jun 2017
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18+ years
Requirements Information
Sex
Female & Male
Age
18+ years
Study Details
Medical Condition
- Unmapped
Study Drug
- Drug: Asfotase alfa
Date
Jun 2016 - Jun 2017
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18+ years years
Requirements Information
Protocol Summary
The purpose of this study was to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of asfotase alfa in adult participants with pediatric-onset HPP.
Trial Locations
Location
Status
Location
Shriners Hospitals for Children
Saint Louis, Missouri, United States, 63110
Status
N/A
Location
Duke University Medical Center
Durham, North Carolina, United States, 27710
Status
N/A
Location
Vanderbilt Medical Center Endocrinology
Nashville, Tennessee, United States, 37232
Status
N/A
Location
University of Würzburg
Würzburg, Germany, 97074
Status
N/A